|
|
Editorial [ Abstract ][ Full text ]
[ Abstract ][ Full text ] Emerging
role of junctophilin-2 as a regulator of calcium handling in the heart
New perspectives on vascular wall signaling: role of perivascular adipocytes and fibroblasts
Non-peptidic
glucagon-like peptide-1 receptor agonists: aftermath of a serendipitous
discovery
Kv1.3:
a potential pharmacological target for diabetes
Hyperpolarization-activated,
cyclic nucleotide-gated (HCN) channels in the regulation of midbrain dopamine
systems
Recent
advances in (patho)physiology of astroglia
Genetics
of stroke
The
role of κ-opioid receptor activation in mediating
antinociception and addiction
Inhibitory
role of oxytocin in psychostimulant-induced psychological dependence and its
effects on dopaminergic and glutaminergic transmission
AMPK
in cardiovascular health and disease
Hypoxia
inducible factor 1 (HIF-1) and cardioprotection
COX-mediated
endothelium-dependent contractions: from the past to recent discoveries
Therapeutic
implications of chemokine-mediated pathways in atherosclerosis: realistic
perspectives and utopias
Caloric restriction and heart function: is there a sensible link?
Cathelicidins
in inflammation and tissue repair: Potential therapeutic applications for
gastrointestinal disorders
Type
І natural killer T cells: naturally born for fighting
Clinical
application and evaluation of anti-TNF-alpha agents for the treatment of
rheumatoid arthritis
Fragile
privileges: autoimmunity in brain and eye
Purinergic
signaling: a novel mechanism in immune surveillance
Autophagic
pathways as new targets for cancer drug development
Chromosome
1q21 amplification and oncogenes in hepatocellular carcinoma
Poly(ADP-ribose)
polymerase inhibitors as promising cancer therapeutics
Potential
therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular
targeting in cancer therapy
ZSTK474,
a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39
drug discovery system
Research
and development of next generation of antibody-based therapeutics
The role of p53 in cell metabolism
Pharmacological
tools for lysophospholipid GPCRs: development of agonists and antagonists for
LPA and S1P receptors [P 1213-1222]
[ Abstract ][ Full text ]
|
Copyright©APS 2010 Add: 294 Tai-Yuan Road, Shanghai 200031, China Phn: 86-21-5492-2821 Fax: 86-21-5492-2823 E-mail: aps@mail.shcnc.ac.cn |
